Top compounds associated with response to MARK2


Feature Type Standardized
Nominal ANOVA
mRNA linifanib CTRPv2 pan-cancer AAC 0.014 0.7
mRNA BRD1835 CTRPv2 pan-cancer AAC -0.015 0.7
mRNA ZSTK474 CTRPv2 pan-cancer AAC 0.014 0.7
mRNA Tipifarnib FIMM pan-cancer AAC -0.051 0.7
mRNA etoposide GDSC1000 pan-cancer AAC -0.014 0.7
mRNA navitoclax:pluripotin (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.014 0.7
mRNA BRD-K27188169 CTRPv2 pan-cancer AAC -0.019 0.7
mRNA AG-014699 GDSC1000 pan-cancer AAC 0.013 0.7
mRNA bafilomycin A1 CTRPv2 pan-cancer AAC 0.064 0.7
mRNA Gefitinib FIMM pan-cancer AAC 0.062 0.7
Download CSV